BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36281182)

  • 1. Meta-analysis of the prognostic value of circulating tumor cells in gastrointestinal cancer.
    Yao Y; Zhu X; Liu W; Jiang J; Jiang H
    Medicine (Baltimore); 2022 Oct; 101(42):e31099. PubMed ID: 36281182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis.
    Eskandarion MR; Eskandarieh S; Tutunchi S; Shakoori Farahani A; Shirkoohi R
    Clin Exp Med; 2024 Mar; 24(1):59. PubMed ID: 38554188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic value of circulating tumor cells in esophageal carcinoma: a meta-analysis.
    Zhang Y; Deng H; Chen G; Tang Z; Mao J; Mi Y; Cui S; Zhang Y; Wang N; Wang L
    Ann Palliat Med; 2020 Nov; 9(6):4271-4282. PubMed ID: 33183057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.
    Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z
    BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant prognostic value of circulating tumor cells in esophageal cancer patients: A meta-analysis.
    Wang S; Du H; Li G
    Oncotarget; 2017 Feb; 8(9):15815-15826. PubMed ID: 28178659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
    Tan Y; Wu H
    Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
    Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
    Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer.
    Zhang ZY; Dai ZL; Yin XW; Li SH; Li SP; Ge HY
    BMC Cancer; 2014 Oct; 14():773. PubMed ID: 25330717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
    Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
    Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of circulating tumor cells detected with the CellSearch system in esophageal cancer patients: a systematic review and meta-analysis.
    Li Y; Wu G; Yang W; Wang X; Duan L; Niu L; Zhang Y; Liu J; Hong L; Fan D
    BMC Cancer; 2020 Jun; 20(1):581. PubMed ID: 32571299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects.
    Pernot S; Badoual C; Terme M; Castan F; Cazes A; Bouche O; Bennouna J; Francois E; Ghiringhelli F; De La Fouchardiere C; Samalin E; Bachet JB; Borg C; Ducreux M; Marcheteau E; Stanbury T; Gourgou S; Malka D; Taieb J
    Eur J Cancer; 2017 Jul; 79():15-22. PubMed ID: 28456090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis.
    Huang C; Lin X; He J; Liu N
    Gynecol Oncol; 2021 May; 161(2):613-620. PubMed ID: 33674144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in peripheral blood of pancreatic cancer patients and their prognostic role: a systematic review and meta-analysis.
    Wang Y; Yu X; Hartmann D; Zhou J
    HPB (Oxford); 2020 May; 22(5):660-669. PubMed ID: 31786054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
    Wang S; Liu X; Lv H; Yu J; Li H
    J Evid Based Med; 2024 Apr; ():. PubMed ID: 38600712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between circulating tumor cells in the peripheral blood and the prognosis of gastric cancer patients: a meta-analysis.
    Jin T; Liang PP; Chen ZH; He FJ; Li ZD; Chen ZW; Hu JK; Yang K
    Ther Adv Med Oncol; 2023; 15():17588359231183678. PubMed ID: 37435560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
    Cui K; Ou Y; Shen Y; Li S; Sun Z
    Medicine (Baltimore); 2020 Oct; 99(40):e22242. PubMed ID: 33019399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
    Han L; Chen W; Zhao Q
    Tumour Biol; 2014 Mar; 35(3):2473-80. PubMed ID: 24218336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab.
    Magbanua MJM; Savenkov O; Asmus EJ; Ballman KV; Scott JH; Park JW; Dickler M; Partridge A; Carey LA; Winer EP; Rugo HS
    Clin Cancer Res; 2020 Sep; 26(18):4911-4920. PubMed ID: 32586939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.